Pulse Biosciences CEO Barrett resigns; Danahy, Uecker named interim executives

PULSE BIOSCIENCES, INC.

CEO Burke T. Barrett resigns effective Dec 6, 2024; also leaves board Dec 2, 2024.
Resignation not due to any disagreement; company affirms development and clinical plans on track.
Severance: 12 months base salary (24 installments), $106,009.61 bonus, partial vesting of 101,000 options at $7.45, COBRA.
Chief Commercial Officer Kevin Danahy and CTO Darrin Uecker serve as interim principal executive and financial officers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.